The University of Chicago Header Logo

Connection

Peter Sand to Humans

Back to Details
This is a "connection" page, showing publications Peter Sand has written about Humans.
Peter Sand
Connection Strength
1.378
Humans
  1. The female urethra: urethral function throughout a woman's lifetime. Int Urogynecol J. 2023 06; 34(6):1175-1186.
    View in: PubMed
    Score: 0.030
  2. Twelve-month Durability of a Fully-implanted, Nickel-sized and Shaped Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome with Urgency Urinary Incontinence: A Single-Arm, Prospective Study. Urology. 2021 11; 157:71-78.
    View in: PubMed
    Score: 0.026
  3. A Comparison of Sacrospinous Hysteropexy Augmented With Polypropylene Mesh Versus Human Dermis at 12-Month Follow-up: An Ambidirectional Study. Female Pelvic Med Reconstr Surg. 2020 10; 26(10):607-611.
    View in: PubMed
    Score: 0.025
  4. Can patients independently identify their urinary incontinence symptoms? Int Urogynecol J. 2021 Feb; 32(2):381-385.
    View in: PubMed
    Score: 0.025
  5. Subjective and objective responses to PTNS and predictors for success: a retrospective cohort study of percutaneous tibial nerve stimulation for overactive bladder. Int Urogynecol J. 2019 08; 30(8):1253-1259.
    View in: PubMed
    Score: 0.022
  6. Counseling in urogynecology: A difficult task, or simply good surgeon-patient communication? Int Urogynecol J. 2018 07; 29(7):943-948.
    View in: PubMed
    Score: 0.022
  7. A review of the impact of pregnancy and childbirth on pelvic floor function as assessed by objective measurement techniques. Int Urogynecol J. 2018 Mar; 29(3):327-338.
    View in: PubMed
    Score: 0.021
  8. Postoperative pain and perceptions of recuperation after suture- and mesh-based apical sacrospinous ligament suspension. Int J Gynaecol Obstet. 2017 Oct; 139(1):95-99.
    View in: PubMed
    Score: 0.020
  9. A multicenter, prospective trial to evaluate mesh-augmented sacrospinous hysteropexy for uterovaginal prolapse. Int Urogynecol J. 2015 May; 26(5):743-8.
    View in: PubMed
    Score: 0.017
  10. Sexual function in women with anal incontinence using a new instrument: the PISQ-IR. Int Urogynecol J. 2015 May; 26(5):657-63.
    View in: PubMed
    Score: 0.017
  11. Vesico-ureteral reflux in women with idiopathic high-pressure detrusor overactivity: prevalence, bladder function, and effect on the upper urinary tract. Int Urogynecol J. 2014 Oct; 25(10):1405-10.
    View in: PubMed
    Score: 0.016
  12. Cost effectiveness of radiofrequency microremodeling for stress urinary incontinence. Int Urogynecol J. 2014 Apr; 25(4):517-23.
    View in: PubMed
    Score: 0.016
  13. The diagnosis and management of lower urinary tract symptoms in multiple sclerosis patients. Dis Mon. 2013 Jul; 59(7):261-8.
    View in: PubMed
    Score: 0.015
  14. The reliability and validity of the revised Diabetes Family Conflict Scale questionnaire, in a sample of Swedish children. Acta Paediatr. 2013 Jun; 102(6):650-4.
    View in: PubMed
    Score: 0.015
  15. Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study. J Urol. 2013 Sep; 190(3):958-64.
    View in: PubMed
    Score: 0.015
  16. Oxybutynin: past, present, and future. Int Urogynecol J. 2013 Apr; 24(4):595-604.
    View in: PubMed
    Score: 0.014
  17. Measuring the success of combined intravesical dimethyl sulfoxide and triamcinolone for treatment of bladder pain syndrome/interstitial cystitis. Int Urogynecol J. 2013 Feb; 24(2):303-11.
    View in: PubMed
    Score: 0.014
  18. The reliability of the Health Related Quality Of Life questionnaire PedsQL 3.0 Diabetes Module™ for Swedish children with type 1 diabetes. Acta Paediatr. 2012 Aug; 101(8):e344-9.
    View in: PubMed
    Score: 0.014
  19. Long-term safety, tolerability and efficacy of fesoterodine in subjects with overactive bladder symptoms stratified by age: pooled analysis of two open-label extension studies. Drugs Aging. 2012 Feb 01; 29(2):119-31.
    View in: PubMed
    Score: 0.014
  20. Efficacy and safety of oxybutynin chloride topical gel for women with overactive bladder syndrome. Am J Obstet Gynecol. 2012 Feb; 206(2):168.e1-6.
    View in: PubMed
    Score: 0.013
  21. Foreign-body granuloma after injection of calcium hydroxylapatite for type III stress urinary incontinence. Obstet Gynecol. 2011 Aug; 118(2 Pt 2):418-421.
    View in: PubMed
    Score: 0.013
  22. Extrasphincteric perianal fistulae after sacrospinous fixation for apical prolapse. Obstet Gynecol. 2011 Feb; 117(2 Pt 2):438-440.
    View in: PubMed
    Score: 0.013
  23. Once-daily trospium chloride 60 mg extended release in subjects with overactive bladder syndrome who use multiple concomitant medications: Post hoc analysis of pooled data from two randomized, placebo-controlled trials. Drugs Aging. 2011 Feb 01; 28(2):151-60.
    View in: PubMed
    Score: 0.013
  24. Trospium chloride once-daily extended release is efficacious and tolerated in elderly subjects (aged = 75 years) with overactive bladder syndrome. BJU Int. 2011 Feb; 107(4):612-20.
    View in: PubMed
    Score: 0.013
  25. Diagnosis and treatment of interstitial cystitis/painful bladder syndrome: a review. J Womens Health (Larchmt). 2010 Jun; 19(6):1185-93.
    View in: PubMed
    Score: 0.012
  26. Fesoterodine in patients with overactive bladder syndrome: can the severity of baseline urgency urinary incontinence predict dosing requirement? BJU Int. 2010 Sep; 106(6):816-21.
    View in: PubMed
    Score: 0.012
  27. Editorial comment on "An International Urogynecological Association (IUGA)/International continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction". Neurourol Urodyn. 2010; 29(1):3.
    View in: PubMed
    Score: 0.012
  28. Editorial comment on "An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction". Int Urogynecol J. 2010 Jan; 21(1):3-4.
    View in: PubMed
    Score: 0.012
  29. Extended-release trospium chloride improves quality of life in overactive bladder. Value Health. 2010 Mar-Apr; 13(2):251-7.
    View in: PubMed
    Score: 0.012
  30. The evolution of transdermal therapy for overactive bladder. Curr Urol Rep. 2009 Sep; 10(5):338-41.
    View in: PubMed
    Score: 0.012
  31. Trospium chloride extended release is effective and well tolerated in women with overactive bladder syndrome. Int Urogynecol J Pelvic Floor Dysfunct. 2009 Dec; 20(12):1431-8.
    View in: PubMed
    Score: 0.012
  32. Efficacy and tolerability of fesoterodine in women with overactive bladder. Int Urogynecol J Pelvic Floor Dysfunct. 2009 Jul; 20(7):827-35.
    View in: PubMed
    Score: 0.011
  33. Patient-reported most bothersome symptoms in OAB: post hoc analysis of data from a large, open-label trial of solifenacin. Int Urogynecol J Pelvic Floor Dysfunct. 2009 Jun; 20(6):667-75.
    View in: PubMed
    Score: 0.011
  34. Impact of transdermal oxybutynin on work productivity in patients with overactive bladder: results from the MATRIX study. Pharmacoeconomics. 2009; 27(4):329-39.
    View in: PubMed
    Score: 0.011
  35. Predictors of persistent detrusor overactivity after transvaginal sling procedures. Am J Obstet Gynecol. 2008 Dec; 199(6):696.e1-7.
    View in: PubMed
    Score: 0.011
  36. Subjective measures of efficacy and quality of life in overactive bladder syndrome. Curr Urol Rep. 2008 Sep; 9(5):368-72.
    View in: PubMed
    Score: 0.011
  37. Evolving trends in the successful management of interstitial cystitis/painful bladder syndrome. J Reprod Med. 2008 Sep; 53(9):651-6.
    View in: PubMed
    Score: 0.011
  38. Treatment modalities, health care resource utilization, and costs in patients diagnosed with interstitial cystitis. Am J Obstet Gynecol. 2008 Jul; 199(1):71.e1-10.
    View in: PubMed
    Score: 0.011
  39. Association between response to pentosan polysulfate sodium therapy for interstitial cystitis and patient questionnaire-based treatment satisfaction. Curr Med Res Opin. 2008 Aug; 24(8):2259-64.
    View in: PubMed
    Score: 0.011
  40. Cystoscopy for lower urinary tract symptoms in urogynecologic practice: the likelihood of finding bladder cancer. Int Urogynecol J Pelvic Floor Dysfunct. 2008 Jul; 19(7):991-4.
    View in: PubMed
    Score: 0.011
  41. Nocturia: etiology, diagnosis, and treatment. Neurourol Urodyn. 2008; 27(1):34-9.
    View in: PubMed
    Score: 0.010
  42. Time to initiation of pentosan polysulfate sodium treatment after interstitial cystitis diagnosis: effect on symptom improvement. Urology. 2008 Jan; 71(1):57-61.
    View in: PubMed
    Score: 0.010
  43. Evaluation and treatment of female urinary incontinence. Minerva Urol Nefrol. 2007 Dec; 59(4):431-50.
    View in: PubMed
    Score: 0.010
  44. Evaluation and treatment of female urinary incontinence. Panminerva Med. 2007 Sep; 49(3):159-75.
    View in: PubMed
    Score: 0.010
  45. Botulinum toxin A in the overactive bladder: current status and future directions. BJU Int. 2007 Feb; 99(2):247-62.
    View in: PubMed
    Score: 0.010
  46. Detrusor overactivity and urge urinary incontinence following trans obturator versus midurethral slings. Neurourol Urodyn. 2007; 26(1):42-5.
    View in: PubMed
    Score: 0.010
  47. Oxybutynin transdermal system improves the quality of life in adults with overactive bladder: a multicentre, community-based, randomized study. BJU Int. 2007 Apr; 99(4):836-44.
    View in: PubMed
    Score: 0.010
  48. The impact of the overactive bladder syndrome on sexual function: a preliminary report from the Multicenter Assessment of Transdermal Therapy in Overactive Bladder with Oxybutynin trial. Am J Obstet Gynecol. 2006 Dec; 195(6):1730-5.
    View in: PubMed
    Score: 0.010
  49. Is transobturator tape as effective as tension-free vaginal tape in patients with borderline maximum urethral closure pressure? Am J Obstet Gynecol. 2006 Dec; 195(6):1799-804.
    View in: PubMed
    Score: 0.010
  50. Disruptive effects of overactive bladder and urge urinary incontinence in younger women. Am J Med. 2006 Mar; 119(3 Suppl 1):16-23.
    View in: PubMed
    Score: 0.009
  51. Proposed pathogenesis of painful bladder syndrome/interstitial cystitis. J Reprod Med. 2006 Mar; 51(3 Suppl):234-40.
    View in: PubMed
    Score: 0.009
  52. Detrusor overactivity and urge urinary incontinence [corrected] following midurethral versus bladder sling procedures. Am J Obstet Gynecol. 2005 Dec; 193(6):2144-8.
    View in: PubMed
    Score: 0.009
  53. Delivery mode is a major environmental determinant of stress urinary incontinence: results of the Evanston-Northwestern Twin Sisters Study. Am J Obstet Gynecol. 2005 Dec; 193(6):2149-53.
    View in: PubMed
    Score: 0.009
  54. Safety and effectiveness of Colpexin Sphere in the treatment of pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 2006 Sep; 17(5):449-54.
    View in: PubMed
    Score: 0.009
  55. Factors influencing the long-term success of periurethral collagen therapy in the office. Int Urogynecol J Pelvic Floor Dysfunct. 2006 Jun; 17(4):346-51.
    View in: PubMed
    Score: 0.009
  56. Diagnosis and treatment of overactive bladder. Minerva Ginecol. 2005 Oct; 57(5):501-20.
    View in: PubMed
    Score: 0.009
  57. Should women be offered elective cesarean section in the hope of preserving pelvic floor function? Int Urogynecol J Pelvic Floor Dysfunct. 2005 Jul-Aug; 16(4):255-6.
    View in: PubMed
    Score: 0.009
  58. Extended-release formulations of oxybutynin and tolterodine exhibit similar central nervous system tolerability profiles: a subanalysis of data from the OPERA trial. Am J Obstet Gynecol. 2005 Jun; 192(6):1849-54; discussion 1854-5.
    View in: PubMed
    Score: 0.009
  59. Do alterations in vaginal dimensions after reconstructive pelvic surgeries affect the risk for dyspareunia? Am J Obstet Gynecol. 2005 May; 192(5):1573-7.
    View in: PubMed
    Score: 0.009
  60. Histopathologic changes of porcine dermis xenografts for transvaginal suburethral slings. Am J Obstet Gynecol. 2005 May; 192(5):1643-8.
    View in: PubMed
    Score: 0.009
  61. A prospective randomized trial using solvent dehydrated fascia lata for the prevention of recurrent anterior vaginal wall prolapse. Am J Obstet Gynecol. 2005 May; 192(5):1649-54.
    View in: PubMed
    Score: 0.009
  62. Urinary incontinence after multiple gestation and delivery: impact on quality of life. Int Urogynecol J Pelvic Floor Dysfunct. 2005 Sep-Oct; 16(5):334-6.
    View in: PubMed
    Score: 0.009
  63. Site-specific rectocele repair compared with standard posterior colporrhaphy. Obstet Gynecol. 2005 Feb; 105(2):314-8.
    View in: PubMed
    Score: 0.009
  64. Oxybutynin for treatment of urge urinary incontinence and overactive bladder: an updated review. Expert Opin Pharmacother. 2004 Nov; 5(11):2351-9.
    View in: PubMed
    Score: 0.008
  65. Elevating our therapeutic expectations in overactive bladder. J Am Acad Nurse Pract. 2004 Oct; 16(10 Suppl):8-11.
    View in: PubMed
    Score: 0.008
  66. Foley versus intermittent self-catheterization after transvaginal sling surgery: which works best? Urology. 2004 Jul; 64(1):53-7.
    View in: PubMed
    Score: 0.008
  67. A comparison of extended-release oxybutynin and tolterodine for treatment of overactive bladder in women. Int Urogynecol J Pelvic Floor Dysfunct. 2004 Jul-Aug; 15(4):243-8.
    View in: PubMed
    Score: 0.008
  68. Eosinophilic cystitis after bladder instillation with dimethyl sulfoxide. Urology. 2004 Jun; 63(6):1182-3.
    View in: PubMed
    Score: 0.008
  69. Chronic pain syndromes of gynecologic origin. J Reprod Med. 2004 Mar; 49(3 Suppl):230-4.
    View in: PubMed
    Score: 0.008
  70. Prevalence of anal incontinence among mothers of multiples and analysis of risk factors. Am J Obstet Gynecol. 2003 Dec; 189(6):1627-30; discussion 1630-1.
    View in: PubMed
    Score: 0.008
  71. The development of pelvic organ prolapse following isolated Burch retropubic urethropexy. Int Urogynecol J Pelvic Floor Dysfunct. 2003 Nov; 14(5):321-5; discussion 325.
    View in: PubMed
    Score: 0.008
  72. A randomized controlled trial comparing a modified Burch procedure and a suburethral sling: long-term follow-up. Int Urogynecol J Pelvic Floor Dysfunct. 2003 Oct; 14(4):229-33; discussion 233.
    View in: PubMed
    Score: 0.008
  73. Urinary incontinence among mothers of multiples: the protective effect of cesarean delivery. Am J Obstet Gynecol. 2003 Jun; 188(6):1447-50; discussion 1450-3.
    View in: PubMed
    Score: 0.008
  74. A prospective, randomized trial comparing intravesical dimethyl sulfoxide (DMSO) to bupivacaine, triamcinolone, and heparin (BTH), for newly diagnosed interstitial cystitis/painful bladder syndrome (IC/PBS). Neurourol Urodyn. 2023 03; 42(3):615-622.
    View in: PubMed
    Score: 0.007
  75. Extracorporeal electromagnetic stimulation for urinary incontinence and bladder disease. Adv Exp Med Biol. 2003; 539(Pt A):453-65.
    View in: PubMed
    Score: 0.007
  76. Conservative therapy for overactive bladder: pelvic floor exercises. Curr Urol Rep. 2002 Dec; 3(6):458-62.
    View in: PubMed
    Score: 0.007
  77. The use of intraoperative cystoscopy in major vaginal and urogynecologic surgeries. Am J Obstet Gynecol. 2002 Dec; 187(6):1466-71; discussion 1471-2.
    View in: PubMed
    Score: 0.007
  78. Transvaginal Mesh Compared With Native Tissue Repair for Pelvic Organ Prolapse. Obstet Gynecol. 2022 06 01; 139(6):975-985.
    View in: PubMed
    Score: 0.007
  79. Pathophysiology of the overactive bladder. Clin Obstet Gynecol. 2002 Mar; 45(1):182-92.
    View in: PubMed
    Score: 0.007
  80. The safety of reusing injectable collagen: a multicenter microbiological study. Int Urogynecol J Pelvic Floor Dysfunct. 2002; 13(4):232-4; discussion 235.
    View in: PubMed
    Score: 0.007
  81. Protective effect of suburethral slings on postoperative cystocele recurrence after reconstructive pelvic operation. Am J Obstet Gynecol. 2001 Dec; 185(6):1307-12; discussion 1312-3.
    View in: PubMed
    Score: 0.007
  82. Transvaginal bladder neck suspension to Cooper's ligament. Curr Urol Rep. 2001 Oct; 2(5):344-9.
    View in: PubMed
    Score: 0.007
  83. Anterior or posterior sacrospinous vaginal vault suspension: long-term anatomic and functional evaluation. Obstet Gynecol. 2001 Aug; 98(2):199-204.
    View in: PubMed
    Score: 0.007
  84. Comparison of microtransducer and fiberoptic catheters for urodynamic studies. Obstet Gynecol. 2001 Aug; 98(2):253-7.
    View in: PubMed
    Score: 0.007
  85. Methenamine hippurate compared with trimethoprim for the prevention of recurrent urinary tract infections: a randomized clinical trial. Int Urogynecol J. 2022 Mar; 33(3):571-580.
    View in: PubMed
    Score: 0.007
  86. Prospective randomized trial of polyglactin 910 mesh to prevent recurrence of cystoceles and rectoceles. Am J Obstet Gynecol. 2001 Jun; 184(7):1357-62; discussion 1362-4.
    View in: PubMed
    Score: 0.007
  87. Children Treated for Nonsyndromic Craniosynostosis Exhibit Average Adaptive Behavior Skills with Only Minor Shortcomings. Plast Reconstr Surg. 2021 02 01; 147(2):453-464.
    View in: PubMed
    Score: 0.006
  88. Urogynecology: the death of dogma. Int Urogynecol J Pelvic Floor Dysfunct. 2001; 12(1):1-2.
    View in: PubMed
    Score: 0.006
  89. Electromagnetic pelvic floor stimulation for urinary incontinence and bladder disease. Int Urogynecol J Pelvic Floor Dysfunct. 2001; 12(6):401-4.
    View in: PubMed
    Score: 0.006
  90. Transvaginal therapy of genuine stress incontinence. Urology. 2000 Dec 04; 56(6 Suppl 1):23-7.
    View in: PubMed
    Score: 0.006
  91. Electromagnetic pelvic floor stimulation: applications for the gynecologist. Obstet Gynecol Surv. 2000 Nov; 55(11):715-20.
    View in: PubMed
    Score: 0.006
  92. Is it safe to reuse a syringe of glutaraldehyde cross-linked collagen? A microbiological study. J Urol. 2000 Oct; 164(4):1275-6.
    View in: PubMed
    Score: 0.006
  93. Recent developments in pelvic organ prolapse. Curr Opin Obstet Gynecol. 2000 Oct; 12(5):399-404.
    View in: PubMed
    Score: 0.006
  94. Anterior sacrospinous vaginal vault suspension for prolapse. Obstet Gynecol. 2000 Apr; 95(4):612-5.
    View in: PubMed
    Score: 0.006
  95. A prospective randomized study comparing modified Burch retropubic urethropexy and suburethral sling for treatment of genuine stress incontinence with low-pressure urethra. Am J Obstet Gynecol. 2000 Jan; 182(1 Pt 1):30-4.
    View in: PubMed
    Score: 0.006
  96. Cognitive changes in women starting anticholinergic medications for overactive bladder: a prospective study. Int Urogynecol J. 2020 Dec; 31(12):2653-2660.
    View in: PubMed
    Score: 0.006
  97. Evaluation of a new once-daily formulation of oxbutynin for the treatment of urinary urge incontinence. Ditropan XL Study Group. Urology. 1999 Sep; 54(3):420-3.
    View in: PubMed
    Score: 0.006
  98. A Prospective Study to Evaluate Efficacy Using the Nuro Percutaneous Tibial Neuromodulation System in Drug-Naïve Patients With Overactive Bladder Syndrome. Urology. 2019 Sep; 131:77-82.
    View in: PubMed
    Score: 0.006
  99. Anterior Colporrhaphy With and Without Dermal Allograft: A Randomized Control Trial With Long-Term Follow-Up. Female Pelvic Med Reconstr Surg. 2019 May-Jun; 25(3):206-212.
    View in: PubMed
    Score: 0.006
  100. The Cognitive Profile of Children with Nonsyndromic Craniosynostosis. Plast Reconstr Surg. 2019 05; 143(5):1037e-1052e.
    View in: PubMed
    Score: 0.006
  101. Feasibility of a Fully Implanted, Nickel Sized and Shaped Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome with Urgency Urinary Incontinence. J Urol. 2019 05; 201(5):967-972.
    View in: PubMed
    Score: 0.006
  102. Effect of a urinary control insert on quality of life in incontinent women. Int Urogynecol J Pelvic Floor Dysfunct. 1999; 10(2):100-5.
    View in: PubMed
    Score: 0.006
  103. Surgery for urinary incontinence in women: Report from the 6th international consultation on incontinence. Neurourol Urodyn. 2019 02; 38(2):825-837.
    View in: PubMed
    Score: 0.006
  104. Predictors of successful percutaneous tibial nerve stimulation (PTNS) in the treatment of overactive bladder syndrome. Int Urogynecol J. 2019 10; 30(10):1735-1745.
    View in: PubMed
    Score: 0.006
  105. Is There a Relationship Between Patient-Reported Satisfaction and Persistence on Overactive Bladder Syndrome Pharmacotherapy? Female Pelvic Med Reconstr Surg. 2018 May/Jun; 24(3):237-240.
    View in: PubMed
    Score: 0.005
  106. Analysis of long-term Elmiron therapy for interstitial cystitis. Urology 1997;49(Suppl 5A):93-99. J Womens Health. 1998 Mar; 7(2):268-9.
    View in: PubMed
    Score: 0.005
  107. Treatment of detrusor instability with oxybutynin rectal suppositories. Int Urogynecol J Pelvic Floor Dysfunct. 1998; 9(2):100-2.
    View in: PubMed
    Score: 0.005
  108. Pelvic floor electrical stimulation for genuine stress incontinence: who will benefit and when? Int Urogynecol J Pelvic Floor Dysfunct. 1998; 9(5):265-70.
    View in: PubMed
    Score: 0.005
  109. Pregnancy and intercurrent diseases of the urogenital tract. Clin Perinatol. 1997 Jun; 24(2):343-68.
    View in: PubMed
    Score: 0.005
  110. Incisional hernia after suprapubic catheterization. Obstet Gynecol. 1997 May; 89(5 Pt 2):844-6.
    View in: PubMed
    Score: 0.005
  111. Which bladder instillations are more effective? DMSO vs. bupivacaine/heparin/triamcinolone: a retrospective study. Int Urogynecol J. 2017 Sep; 28(9):1335-1340.
    View in: PubMed
    Score: 0.005
  112. The evaluation and management of hematuria in women. Int Urogynecol J Pelvic Floor Dysfunct. 1997; 8(3):156-60.
    View in: PubMed
    Score: 0.005
  113. OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial. J Urol. 2017 02; 197(2S):S216-S223.
    View in: PubMed
    Score: 0.005
  114. Pelvic floor stimulation in the treatment of mixed incontinence complicated by a low-pressure urethra. Obstet Gynecol. 1996 Nov; 88(5):757-60.
    View in: PubMed
    Score: 0.005
  115. Does physician specialty affect persistence to pharmacotherapy among patients with overactive bladder syndrome? Int Urogynecol J. 2017 Mar; 28(3):409-415.
    View in: PubMed
    Score: 0.005
  116. The empty supine stress test as a predictor of intrinsic urethral sphincter dysfunction. Obstet Gynecol. 1996 Jul; 88(1):128-32.
    View in: PubMed
    Score: 0.005
  117. Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study. J Urol. 2016 Sep; 196(3):791-800.
    View in: PubMed
    Score: 0.005
  118. Pelvic floor electrical stimulation in the treatment of genuine stress incontinence: a multicenter, placebo-controlled trial. Am J Obstet Gynecol. 1995 Jul; 173(1):72-9.
    View in: PubMed
    Score: 0.004
  119. Health-related quality of life in preschool children with Type 1 diabetes. Diabet Med. 2015 Jan; 32(1):116-9.
    View in: PubMed
    Score: 0.004
  120. Efficacy and safety of oxybutynin topical gel 3% in patients with urgency and/or mixed urinary incontinence: a randomized, double-blind, placebo-controlled study. Neurourol Urodyn. 2015 Jan; 34(1):37-43.
    View in: PubMed
    Score: 0.004
  121. A new measure of sexual function in women with pelvic floor disorders (PFD): the Pelvic Organ Prolapse/Incontinence Sexual Questionnaire, IUGA-Revised (PISQ-IR). Int Urogynecol J. 2013 Jul; 24(7):1091-103.
    View in: PubMed
    Score: 0.004
  122. The PISQ-IR: considerations in scale scoring and development. Int Urogynecol J. 2013 Jul; 24(7):1105-22.
    View in: PubMed
    Score: 0.004
  123. OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial. J Urol. 2013 Jun; 189(6):2186-93.
    View in: PubMed
    Score: 0.004
  124. Enhanced interpretability of the PFDI-20 with establishment of reference scores among women in the general population. Neurourol Urodyn. 2012 Nov; 31(8):1252-7.
    View in: PubMed
    Score: 0.004
  125. Treatment satisfaction and goal attainment with onabotulinumtoxinA in patients with incontinence due to idiopathic OAB. Int Urogynecol J. 2012 Aug; 23(8):1017-25.
    View in: PubMed
    Score: 0.003
  126. Transvaginal placement of surgical mesh for pelvic organ prolapse: more FDA concerns--positive reactions are possible. Int Urogynecol J. 2012 Jan; 23(1):11-3.
    View in: PubMed
    Score: 0.003
  127. Can pelvic floor injury secondary to delivery be prevented? Int Urogynecol J. 2012 Feb; 23(2):165-73.
    View in: PubMed
    Score: 0.003
  128. Two unusual presentations of bladder diverticula. Obstet Gynecol. 2011 Aug; 118(2 Pt 2):415-417.
    View in: PubMed
    Score: 0.003
  129. Once-daily trospium chloride 60 mg extended-release provides effective, long-term relief of overactive bladder syndrome symptoms. Neurourol Urodyn. 2011 Sep; 30(7):1214-9.
    View in: PubMed
    Score: 0.003
  130. Simple standing incremental cystometry as a screening method for detrusor instability. Obstet Gynecol. 1991 Mar; 77(3):453-7.
    View in: PubMed
    Score: 0.003
  131. Long-term safety, tolerability, and efficacy of fesoterodine treatment in men and women with overactive bladder symptoms. Curr Med Res Opin. 2011 May; 27(5):921-30.
    View in: PubMed
    Score: 0.003
  132. Nongenetic factors associated with stress urinary incontinence. Obstet Gynecol. 2011 Feb; 117(2 Pt 1):251-255.
    View in: PubMed
    Score: 0.003
  133. An International Urogynecological Association (IUGA) / International Continence Society (ICS) joint terminology and classification of the complications related directly to the insertion of prostheses (meshes, implants, tapes) & grafts in female pelvic floor surgery. Int Urogynecol J. 2011 Jan; 22(1):3-15.
    View in: PubMed
    Score: 0.003
  134. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint terminology and classification of the complications related directly to the insertion of prostheses (meshes, implants, tapes) and grafts in female pelvic floor surgery. Neurourol Urodyn. 2011 Jan; 30(1):2-12.
    View in: PubMed
    Score: 0.003
  135. Pharmacokinetics of oxybutynin chloride topical gel: effects of application site, baths, sunscreen and person-to-person transference. Clin Drug Investig. 2011; 31(8):559-571.
    View in: PubMed
    Score: 0.003
  136. The prognostic significance of augmentation of urethral closure pressure and functional length. Int J Gynaecol Obstet. 1990 Oct; 33(2):135-9.
    View in: PubMed
    Score: 0.003
  137. Advances in nonoperative treatment of genuine stress incontinence. Curr Opin Obstet Gynecol. 1990 Aug; 2(4):599-604.
    View in: PubMed
    Score: 0.003
  138. Nonsurgical treatment of detrusor overactivity in postmenopausal women. J Reprod Med. 1990 Aug; 35(8):758-64.
    View in: PubMed
    Score: 0.003
  139. Cystometry, urethrocystometry, and videocystourethrography. Clin Obstet Gynecol. 1990 Jun; 33(2):315-24.
    View in: PubMed
    Score: 0.003
  140. Urge incontinence: estimating environmental and obstetrical risk factors using an identical twin study. Int Urogynecol J. 2010 Aug; 21(8):939-46.
    View in: PubMed
    Score: 0.003
  141. Executive summary: The International Consultation on Incontinence 2008--Committee on: "Dynamic Testing"; for urinary incontinence and for fecal incontinence. Part 1: Innovations in urodynamic techniques and urodynamic testing for signs and symptoms of urinary incontinence in female patients. Neurourol Urodyn. 2010; 29(1):140-5.
    View in: PubMed
    Score: 0.003
  142. Executive Summary: The International Consultation on Incontinence 2008--Committee on: "Dynamic Testing"; for urinary or fecal incontinence. Part 3: Anorectal physiology studies. Neurourol Urodyn. 2010; 29(1):153-8.
    View in: PubMed
    Score: 0.003
  143. Executive summary: The International Consultation on Incontinence 2008--Committee on: "Dynamic Testing"; for urinary or fecal incontinence. Part 2: Urodynamic testing in male patients with symptoms of urinary incontinence, in patients with relevant neurological abnormalities, and in children and in frail elderly with symptoms of urinary incontinence. Neurourol Urodyn. 2010; 29(1):146-52.
    View in: PubMed
    Score: 0.003
  144. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010; 29(1):4-20.
    View in: PubMed
    Score: 0.003
  145. Trospium chloride once-daily extended release is effective and well tolerated for the treatment of overactive bladder syndrome: an integrated analysis of two randomised, phase III trials. Int J Clin Pract. 2009 Dec; 63(12):1715-23.
    View in: PubMed
    Score: 0.003
  146. Urinary frequency and urgency. Obstet Gynecol Clin North Am. 1989 Dec; 16(4):883-96.
    View in: PubMed
    Score: 0.003
  147. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J. 2010 Jan; 21(1):5-26.
    View in: PubMed
    Score: 0.003
  148. Cryosurgery versus dilation and massage for the treatment of recurrent urethral syndrome. J Reprod Med. 1989 Aug; 34(8):499-504.
    View in: PubMed
    Score: 0.003
  149. Arcus-anchored acellular dermal graft compared to anterior colporrhaphy for stage II cystoceles and beyond. Int Urogynecol J Pelvic Floor Dysfunct. 2009 Oct; 20(10):1265-71.
    View in: PubMed
    Score: 0.003
  150. Efficacy and safety of oxybutynin chloride topical gel for overactive bladder: a randomized, double-blind, placebo controlled, multicenter study. J Urol. 2009 Apr; 181(4):1764-72.
    View in: PubMed
    Score: 0.003
  151. Reviewing the ICS 2002 terminology report: the ongoing debate. Neurourol Urodyn. 2009; 28(4):287.
    View in: PubMed
    Score: 0.003
  152. Surgical treatment of stress urinary incontinence: a comparison of the Kelly plication, Marshall-Marchetti-Krantz, and Pereyra procedures. Obstet Gynecol. 1988 Nov; 72(5):820-1.
    View in: PubMed
    Score: 0.003
  153. Vulvodynia & pelvic pain? Think interstitial cystitis. Nurse Pract. 2008 Oct; 33(10):40-5.
    View in: PubMed
    Score: 0.003
  154. The effect of retropubic urethropexy on detrusor stability. Obstet Gynecol. 1988 Jun; 71(6 Pt 1):818-22.
    View in: PubMed
    Score: 0.003
  155. Impact of hysterectomy on stress urinary incontinence: an identical twin study. Am J Obstet Gynecol. 2008 May; 198(5):565.e1-4.
    View in: PubMed
    Score: 0.003
  156. Trospium 60 mg once daily (QD) for overactive bladder syndrome: results from a placebo-controlled interventional study. Urology. 2008 Mar; 71(3):449-54.
    View in: PubMed
    Score: 0.003
  157. Incontinence history as a predictor of detrusor stability. Obstet Gynecol. 1988 Feb; 71(2):257-60.
    View in: PubMed
    Score: 0.003
  158. Hysterectomy and prior incontinence surgery as risk factors for failed retropubic cystourethropexy. J Reprod Med. 1988 Feb; 33(2):171-4.
    View in: PubMed
    Score: 0.003
  159. Efficacy, safety and tolerability of fesoterodine for overactive bladder syndrome. J Urol. 2007 Dec; 178(6):2488-94.
    View in: PubMed
    Score: 0.003
  160. Once daily trospium chloride is effective and well tolerated for the treatment of overactive bladder: results from a multicenter phase III trial. J Urol. 2007 Sep; 178(3 Pt 1):978-83; discussion 983-4.
    View in: PubMed
    Score: 0.003
  161. Supine urethroscopic and standing cystometry as screening methods for the detection of detrusor instability. Obstet Gynecol. 1987 Jul; 70(1):57-60.
    View in: PubMed
    Score: 0.003
  162. Cryotherapy for the treatment of proximal urethral condyloma acuminatum. J Urol. 1987 May; 137(5):874-6.
    View in: PubMed
    Score: 0.002
  163. Multicenter prospective randomized 52-week trial of calcium hydroxylapatite versus bovine dermal collagen for treatment of stress urinary incontinence. Urology. 2007 May; 69(5):876-80.
    View in: PubMed
    Score: 0.002
  164. Safety and tolerability of extended-release oxybutynin once daily in urinary incontinence: combined results from two phase 4 controlled clinical trials. Int Urol Nephrol. 2007; 39(4):1069-77.
    View in: PubMed
    Score: 0.002
  165. The low pressure urethra as a factor in failed retropubic urethropexy. Obstet Gynecol. 1987 Mar; 69(3 Pt 1):399-402.
    View in: PubMed
    Score: 0.002
  166. Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT). Clin Ther. 2006 Nov; 28(11):1935-46.
    View in: PubMed
    Score: 0.002
  167. Uninhibited urethral relaxation: an unusual cause of incontinence. Obstet Gynecol. 1986 Nov; 68(5):645-8.
    View in: PubMed
    Score: 0.002
  168. Evaluation of male consorts of women with genital human papilloma virus infection. Obstet Gynecol. 1986 Nov; 68(5):679-81.
    View in: PubMed
    Score: 0.002
  169. Methotrexate inhibition of normal trophoblasts in vitro. Am J Obstet Gynecol. 1986 Aug; 155(2):324-9.
    View in: PubMed
    Score: 0.002
  170. Voiding dysfunction in the adolescent. Obstet Gynecol Surv. 1986 Jun; 41(6):342-7.
    View in: PubMed
    Score: 0.002
  171. Perceptions and behaviours of women with bladder control problems. Fam Pract. 2006 Oct; 23(5):568-77.
    View in: PubMed
    Score: 0.002
  172. Effect of parity on sexual function: an identical twin study. Obstet Gynecol. 2006 Apr; 107(4):765-70.
    View in: PubMed
    Score: 0.002
  173. Transdermal delivery of drugs for urologic applications: basic principles and applications. Urology. 2006 Apr; 67(4):657-64.
    View in: PubMed
    Score: 0.002
  174. Management of incontinence for family practice physicians. Am J Med. 2006 Mar; 119(3 Suppl 1):37-40.
    View in: PubMed
    Score: 0.002
  175. Risk factors for female anal incontinence: new insight through the Evanston-Northwestern twin sisters study. Obstet Gynecol. 2005 Oct; 106(4):726-32.
    View in: PubMed
    Score: 0.002
  176. The effect of preemptive pudendal nerve blockade on pain after transvaginal pelvic reconstructive surgery. Obstet Gynecol. 2005 Oct; 106(4):782-8.
    View in: PubMed
    Score: 0.002
  177. TVT versus SPARC: comparison of outcomes for two midurethral tape procedures. Int Urogynecol J Pelvic Floor Dysfunct. 2006 Feb; 17(2):125-30.
    View in: PubMed
    Score: 0.002
  178. Successful treatment of Zoon's vulvitis with high potency topical steroid. Int Urogynecol J Pelvic Floor Dysfunct. 2006 Feb; 17(2):178-9.
    View in: PubMed
    Score: 0.002
  179. The tensile strength of Cooper's ligament suturing: comparison of abdominal and transvaginal techniques. Int Urogynecol J Pelvic Floor Dysfunct. 2004 Nov-Dec; 15(6):425-7; discussion 428.
    View in: PubMed
    Score: 0.002
  180. Chronic pelvic actinomycosis following a bone anchored sling procedure. J Urol. 2004 Jun; 171(6 Pt 1):2381.
    View in: PubMed
    Score: 0.002
  181. Incidence of pubic osteomyelitis after bladder neck suspension using bone anchors. Urology. 2004 Apr; 63(4):704-8.
    View in: PubMed
    Score: 0.002
  182. Repeat gestational trophoblastic disease. Obstet Gynecol. 1984 Feb; 63(2):140-4.
    View in: PubMed
    Score: 0.002
  183. Cholecystokinin- and cholecystokinin-B-receptor gene polymorphisms in panic disorder. J Neural Transm Suppl. 2004; (68):147-56.
    View in: PubMed
    Score: 0.002
  184. Comparative efficacy and safety of transdermal oxybutynin and oral tolterodine versus placebo in previously treated patients with urge and mixed urinary incontinence. Urology. 2003 Aug; 62(2):237-42.
    View in: PubMed
    Score: 0.002
  185. Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: results of the OPERA trial. Mayo Clin Proc. 2003 Jun; 78(6):687-95.
    View in: PubMed
    Score: 0.002
  186. Long-term safety of extended-release oxybutynin chloride in a community-dwelling population of participants with overactive bladder: a one-year study. Int Urol Nephrol. 2002; 34(1):43-9.
    View in: PubMed
    Score: 0.002
  187. Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study. Mayo Clin Proc. 2001 Apr; 76(4):358-63.
    View in: PubMed
    Score: 0.002
  188. Early-stage ovarian carcinoma presenting with irritative voiding symptoms and urge incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2001; 12(5):342-4.
    View in: PubMed
    Score: 0.002
  189. Update on extracorporeal magnetic innervation (EXMI) therapy for stress urinary incontinence. Urology. 2000 Dec 04; 56(6 Suppl 1):82-6.
    View in: PubMed
    Score: 0.002
  190. Osteomyelitis of the pubis following suspension of the neck of the bladder with use of bone anchors. A report of four cases. J Bone Joint Surg Am. 1999 Dec; 81(12):1736-40.
    View in: PubMed
    Score: 0.001
  191. Extracorporeal magnetic innervation therapy for stress urinary incontinence. Urology. 1999 Jun; 53(6):1108-11.
    View in: PubMed
    Score: 0.001
  192. [Signs of inflammation and hemorrhage in the rectal mucosa during therapy of rectal constipation with phosphate enemata and bisacodyl rectal tube]. Ugeskr Laeger. 1978 Aug 21; 140(34):2041-4.
    View in: PubMed
    Score: 0.001
  193. Pelvic floor electrical stimulation for the treatment of urge and mixed urinary incontinence in women. Urology. 1997 Dec; 50(6):934-40.
    View in: PubMed
    Score: 0.001
  194. Effectiveness of a urinary control insert in the management of stress urinary incontinence: early results of a multicenter study. Urology. 1996 May; 47(5):629-36.
    View in: PubMed
    Score: 0.001
  195. Psychopathological and neuropsychological effects of 8-days' corticosteroid treatment. A prospective study. Psychoneuroendocrinology. 1996 Jan; 21(1):25-31.
    View in: PubMed
    Score: 0.001
  196. The cotton swab test. Receiver-operating characteristic curves. J Reprod Med. 1995 Jan; 40(1):42-6.
    View in: PubMed
    Score: 0.001
  197. [Alcohol and drug abuse as risk factors for violence and delinquency in schizophrenic patients]. Psychiatr Prax. 1993 Sep; 20(5):172-5.
    View in: PubMed
    Score: 0.001
  198. Unsuccessful Burch retropubic urethropexy: a case-controlled urodynamic study. Am J Obstet Gynecol. 1989 Feb; 160(2):452-8.
    View in: PubMed
    Score: 0.001
  199. A urodynamic appraisal of success and failure after retropubic urethropexy. J Reprod Med. 1987 Sep; 32(9):693-6.
    View in: PubMed
    Score: 0.001
  200. Choriocarcinoma associated with ectopic pregnancy. Obstet Gynecol. 1986 Aug; 68(2):286-7.
    View in: PubMed
    Score: 0.001
  201. Conservative treatment of ectopic pregnancy with methotrexate. Am J Obstet Gynecol. 1986 Jun; 154(6):1299-306.
    View in: PubMed
    Score: 0.001
  202. Toxic shock syndrome following carbon dioxide laser treatment of genital tract condyloma acuminatum. Am J Obstet Gynecol. 1986 Jan; 154(1):145-6.
    View in: PubMed
    Score: 0.001
  203. Pregnancy outcome subsequent to consecutive hydatidiform moles. Am J Obstet Gynecol. 1982 Apr 15; 142(8):1060-1.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.